Related Experiment Video
Updated: Oct 14, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Delirious mania in a patient with COVID-19 pneumonia
Peter M Haddad1, Majid Alabdulla2, Javed Latoo3
1Psychiatry, Hamad Medical Corporation, Doha, Qatar Phaddad@hamad.qa.
Abstract:
Delirious mania (the coexistence of delirium and mania) is described in the literature but not recognised in standard nosologies. We report a woman in her late 30s, with no psychiatric history, who presented with concurrent symptoms of mania and delirium. She was diagnosed with COVID-19 pneumonia (positive reverse transcription-PCR test). There was no history of substance misuse or concurrent medical illness. CT head scan was normal as were blood investigations, other than elevated inflammatory markers. She received standard treatment for COVID-19 pneumonia and lorazepam and quetiapine to treat her neuropsychiatric symptoms. She made a full recovery after 9 days. She was apyrexial with normal oxygen saturation throughout her illness. The case shows that severe neuropsychiatric symptoms can complicate otherwise mild COVID-19 pneumonia with neuroinflammation being a possible mechanism. A diagnosis of delirious mania appears to better capture the complexity of the presentation than a diagnosis of mania or delirium alone.
Insights
Delirious mania, a combination of delirium and mania, can occur with mild COVID-19 pneumonia. This case highlights neuroinflammation as a potential cause for these severe neuropsychiatric symptoms.
Area of Science:
- Neuroscience
- Psychiatry
- Infectious Diseases
Background:
- Delirious mania, the concurrent presentation of delirium and mania, is not formally recognized in standard diagnostic classifications.
- The neuropsychiatric manifestations of COVID-19 are diverse and can include symptoms beyond typical respiratory illness.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-IV
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Acute Respiratory Failure-III

